Found: 10
Select item for more details and to access through your institution.
A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E175, doi. 10.1002/ajh.26136
- By:
- Publication type:
- Article
Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 148, n. 2, p. 315, doi. 10.1007/s10549-014-3163-8
- By:
- Publication type:
- Article
A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types.
- Published in:
- NPJ Precision Oncology, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41698-018-0051-4
- By:
- Publication type:
- Article
Nonmyeloablative Conditioning Regimen to Increase Engraftment of Gene-modified Hematopoietic Stem Cells in Young Rhesus Monkeys.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 5, p. 1033, doi. 10.1038/mt.2011.312
- By:
- Publication type:
- Article
Lentiviral Vector Transduction of a Dominant-negative Rev Gene Into Human CD34<sup>+</sup> Hematopoietic Progenitor Cells Potently Inhibits Human Immunodeficiency Virus-1 Replication.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 1, p. 76, doi. 10.1038/sj.mt.6300025
- By:
- Publication type:
- Article
Profiling Cancer Gene Mutations in Clinical Formalin-Fixed, Paraffin-Embedded Colorectal Tumor Specimens Using Targeted Next-Generation Sequencing.
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 336, doi. 10.1634/theoncologist.2013-0180
- By:
- Publication type:
- Article
Next Generation MUT-MAP, a High-Sensitivity High-Throughput Microfluidics Chip-Based Mutation Analysis Panel.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090761
- By:
- Publication type:
- Article
Targeted Biomarker Profiling of Matched Primary and Metastatic Estrogen Receptor Positive Breast Cancers.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088401
- By:
- Publication type:
- Article
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216864
- By:
- Publication type:
- Article
CpeR is an activator required for expression of the phycoerythrin operon (cpeBA ) in the cyanobacterium Fremyella diplosiphon and is encoded in the phycoerythrin linker-polypeptide operon (cpeCDESTR ).
- Published in:
- Molecular Microbiology, 2002, v. 44, n. 6, p. 1517, doi. 10.1046/j.1365-2958.2002.02966.x
- By:
- Publication type:
- Article